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Abstract
Using mice that lack recombination activating gene-2 (Rag2), we have found that bone marrow-derived plasmacytoid
dendritic cells (pDCs) as main producers of interferon-a (IFNa) require Rag2 for normal development. This is a novel function
for Rag2, whose classical role is to initiate B and T cell development. Here we showed that a population of common
progenitor cells in the mouse bone marrow possessed the potential to become either B cells or pDCs upon appropriate
stimulations, and the lack of Rag2 hindered the development of both types of progeny cells. A closer look at pDCs revealed
that Rag22/2 pDCs expressed a high level of Ly6C and were defective at producing IFNa in response to CpG, a ligand for
toll-like receptor 9. This phenotype was not shared by Rag12/2 pDCs. The induction of CCR7, CD40 and CD86 with CpG,
however, was normal in Rag22/2 pDCs. In addition, Rag22/2 pDCs retained the function to promote antibody class
switching and plasma cell formation through producing IL-6. Further analysis showed that interferon regulatory factor-8,
a transcription factor important for both IFNa induction and pDC development, was dysregulated in pDCs lacking Rag2.
These results indicate that the generation of interferon response in pDCs requires Rag2 and suggest the lymphoid origin of
bone marrow-derived pDCs.
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Introduction
Plasmacytoid dendritic cells (pDCs) were first described as
‘‘plasma cell-like’’ by pathologists [1] and later found to be
identical to the ‘‘professional interferon-producing cells’’ in the
peripheral blood and secondary lymph organs [2,3]. Their
primary function is to produce type I interferons but they also
produce other cytokines and are involved in antigen presentation
[4,5]. They are considered a functional link between innate and
adaptive immune responses.
Whether pDCs originate from the myeloid or lymphoid lineage
has been a focus of debate for the last decade. The myeloid
hypothesis is supported by the observations that Flt3+ myeloid
progenitors can generate pDCs [6] and that the depletion of
common lymphoid progenitors does not appear to affect pDC
generation [7]. However, more evidence supports the lymphoid
hypothesis. First, adoptive transfer experiments have shown the
generation of pDCs from lymphoid progenitors [6]. Second,
common myeloid progenitor-derived pDCs have been shown to
express lymphoid-associated genes such as pre-Ta and recombi-
nation activating gene-1 (Rag1) [8]. Third, pDCs share many
molecular features of B cells, such as the expression of B220, Tdt,
VpreB, Rag1, Rag2, and D-to-J rearrangement of the immuno-
globulin (Ig) heavy chain locus [8–10]. Why pDCs need to express
B cell-specific genes and rearrange the Ig heavy chains locus is
unknown but it raises the possibility that pDCs and B cells may
have differentiated from the same progenitor cells.
Rag proteins play an essential role in V(D)J recombination by
inducing site-specific cleavage and recombination of variable (V),
joining (J), and sometimes diversity (D) gene segments that are
initially separated in the germline configuration [11–13]. Although
they were originally identified in T and B cells [14,15], Rag1 and
Rag2 transcripts have been found in non-T/B cells such as
dendritic cells [8,16] and natural killer cells [17]. In addition,
Rag1 has been shown to function in neurogenesis in the central
nervous system [18,19]. However, whether and how Rag proteins
may play a role in non-T/B cells remain unclear.
Here we show that Rag2 is required for toll-like receptor 9
(TLR9)-mediated induction of IFNa in bone marrow-derived
pDCs. Our results show that, although the numbers and
expansion of pDCs are similar between wildtype and Rag22/2
mice, Rag22/2 pDCs appear to be defective at producing IFNa in
vitro and in vivo in response to the TLR9 ligand, CpG. In
contrast, Rag22/2 pDCs retain the functions to (1) upregulate
functional surface markers CCR7, CD40 and CD86 in response to
CpG and (2) promote antibody class switching and plasma cell
formation, indicating that Rag2 specifically regulates CpG-
induced IFNa production. In addition, we show that interferon
regulatory factor-8 (IRF8), an essential transcription factor that
regulates pDC development, is dysregulated in pDCs lacking
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Rag2. These results suggest Rag2 as an important regulator of
interferon response in pDCs.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of theNational Institutes ofHealth.Rag12/2 andRag22/2
mice, which were of BALB/c background, had been housed at
California Institute of Technology (Animal Assurance Number:
A3426-01) for several years prior to the start of the study. Age-
matched wildtype mice were purchased from Jackson Laboratory.
Theprotocolwasapprovedby the InstitutionalAnimalCareandUse
Committee (IACUC) of California Institute of Technology (IACUC
protocol number 1403-05T). All efforts were made to minimize
suffering and mice were euthanized by CO2 inhalation followed by
exsanguination by transcardiac blood collection.
Cell Isolation and Culture
For the isolation of progenitor cells, bone marrow cells were
sorted using a FACSAria sorter (BD Biosciences) for a population
that was lineage2B220+Flt3+CD43+CD24+, where the lineage
markers were Ly6C, PDCA-1, CD11c, Ter-119, and CD3e. For
other experiments, bone marrow cells and splenocytes were
isolated and sorted for different cell populations using magnetic-
activated cell separation (MACS) kits (Miltenyi Biotec). The
isolation steps were repeated whenever necessary to achieve 90%
purity as determined by flow cytometry. Mouse CD19 microbeads
were used for the isolation of B cells. Mouse PDCA-1 microbeads
were used for the isolation of pDCs. Ly6Chi and Ly6C2/low cells
were also separated with MACS. Cells were cultured in RPMI
1640 medium supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, 50 mM b-mercaptoethanol, 10 mM HEPES, 1 mM
sodium pyruvate, 16 MEM nonessential amino acids, and
penicillin/streptomycin. In some experiments, cells were cultured
with 100 ng/mL mouse Flt3 ligand (R & D Systems), 5 mM of
mouse Type A CpG oligonucleotide ODN1585 (InvivoGen),
10 ng/mL mouse IL-7 (R & D Systems), or 0.5 mg/mL of an anti-
mouse IL-6 blocking antibody or isotype control (eBioscience).
Reverse Transcription-quantitative PCR (RT-qPCR)
Total RNA was isolated from total bone marrow cells or
MACS-sorted cells (.90% purity as determined by flow
cytometry) using RNeasy Mini Kit (Qiagen) per manufacturer’s
instructions. Reverse transcription was performed by using
iScriptTM cDNA Synthesis Kit (Bio-Rad). SYBR Green-based
quantitative real-time PCR was conducted with a 7300 Realtime
PCR system (Applied Biosystems) to assay Rag1, Rag2, IRF8, and
L32 mRNA amounts with gene-specific primers (sequences
available upon request). For all experiments, mRNA expression
was normalized to that of a relatively stable ribosomal protein L32
[20].
Wright’s Stain
For Wright’s stain, single cell suspensions were cytospinned onto
slides, air-dried, stained, and examined on an Olympus BX-51
microscope and photographed using a Spot Digital Camera.
Flow Cytometry
Fluorophore-conjugated monoclonal antibodies specific to
PDCA-1, B220, Ly6C, CD11c, CD11b, TLR9 (intracellular),
CD40, CD86, CCR7, or CD138 (eBioscience) were used to stain
cells. After washing, stained cells were assayed with a BD
FACSCalibur flow cytometer (BD Biosciences). Results were
processed with FlowJo software (Tree Star).
Enzyme-linked Immunosorbent Assays (ELISAs)
Mouse IFNa, IL-6, IgM, and IgG2a ELISAs were performed
with cytokine-specific kits (PBL Interferon Source or eBioscience)
or antibody-specific kits (Bethyl Laboratories) and carried out
according to the manufacturer’s instructions.
In vivo CpG Stimulation
To prepare each milliliter of the ODN1585/1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) complex for in vivo CpG
stimulation, 100 mL of 500 mM ODN1585 was mixed with 20 mL
of PBS and 30 mL (30 mg) of DOTAP (Roche), incubated for
15 min at room temperature, and then diluted with 850 mL of
PBS to make 50 mM of the complex. For each mouse, 150 mL of
ODN1585/DOTAP complex was injected intravenously.
Statistical Analysis
Student’s two-tailed t tests were performed using Microsoft
Excel statistical software module (Microsoft). All data, unless
specified, are shown as the mean + standard error, and the
difference was considered statistically significant when the P value
was less than.05.
Results
Requirement for Rag2 in pDC Development
In the mouse bone marrow, Rag1 and Rag2 proteins are
expressed in early stages of B cells to regulate V(D)J rearrangement
of the Ig heavy and light chain loci. PDCs have also been shown to
express Rag proteins and undergo D-to-J rearrangement [9],
raising the possibility that pDCs and B cells may have
differentiated from the same progenitor cells. Thus, we sorted
Hardy fractions B-C from mouse bone marrow cells and examined
the potential of the sorted cells to generate B cells and pDCs,
respectively. These fractions of cells were previously defined as
pre-pro-B and pro-B cells (lineage2B220+Flt3+CD43+CD24+) and
had D-to-J, but not V-to-DJ rearrangements [21]. As anticipated,
the sorted progenitor cells generated CD19+m+ pre-B cells in vitro
upon stimulation with mouse IL-7 (Fig. 1A, upper panels) and the
expression of m heavy chain was abolished in the absence of Rag2
(Fig. 1A, lower panels). Importantly, the same progenitor cells were
also able to generate IFNa-producing PDCA-1+ pDCs in the
presence of Flt3 ligand and a TLR9 ligand (Type A CpG
oligonucleotide ODN1585), regardless of Rag2 expression
(Fig. 1B–C). However, we observed that pDCs generated from
Rag22/2 progenitors expressed a higher level of Ly6C (Fig. 1B)
and produced significantly less IFNa than Rag2+/+ pDCs (Fig. 1C;
p,.05). These results indicate that B cells and pDCs may be
generated from a common population of progenitor cells and that
Rag2 may be required for the development of both types of
progeny cells.
We next compared the expression of Rag1 and Rag2 in pDCs
versus B cells and other cells in the bone marrow. As anticipated,
both Rag1 and Rag2 were highly expressed in pDCs and B cells
but not in other cells (Fig. 2A). Importantly, we found that while
Rag1 was expressed equally in pDCs and B cells, the expression of
Rag2 was 3-fold higher in pDCs than in B cells (p,.05), indicating
that Rag2 is preferentially expressed in pDCs. This indicates that
Rag2 might have a unique function in pDCs. In addition, we
found that bone marrow-derived Rag22/2 pDCs were morpho-
logically different from Rag2+/+ pDCs (Fig. 2B). While Rag2+/+
pDCs were uniformly ‘‘plasma cell-like’’ under the microscope,
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there appeared to be two subpopulations of Rag22/2 PDCA-1+
pDCs in the bone marrow–one was morphologically similar to
Rag2+/+ pDC but the other possessed the morphology of activated
interdigitating pDCs [1]. This also suggests that Rag2 may have
an unknown function in pDCs.
Phenotypic Difference between Rag2+/+ and Rag22/2
pDCs
PDCs are phenotypically defined as B220+CD11c+/lowPDCA-
1+ cells in mice [1]. Siglec-H, another pDC-specific marker, is
uniformly expressed on B220+CD11c+/lowPDCA-1+ cells that have
not been previously stimulated [22]. Although PDCA-1 is
expressed at a low level in some subpopulations of B cells and
inducible in many cells upon activation [23], we chose to use
Figure 1. Generation of B cells and pDCs from a common population of mouse progenitor cells. Bone marrow cells were isolated from
Rag2+/+ and Rag22/2 mice, sorted with a FACSAria sorter for a population that was lineage2B220+Flt3+CD43+CD24+, where the lineage markers were
Ly6C, PDCA-1, CD11c, Ter-119, and CD3e. A. Generation of B cells from the sorted cells. The sorted cells (26 105 sorted cells/200 mL/well) were
cultured in the presence of IL-7 for 4 days and analyzed by using flow cytometry. Over 90% of the derived cells were CD19+ and some of them also
expressed surface Igm heavy chain (m-HC), indicating the presence of pre-B cells. B. Generation of pDCs from the sorted cells. The sorted cells (26105
sorted cells/200 mL/well) were cultured in the presence of Flt3 ligand and ODN1585 for 4 days and analyzed by flow cytometry. About 90% of
progeny cells were PDCA-1+. The expression levels of Ly6C on the surface of PDCA-1+ cells are also shown. Representative plots of 3 independent
experiments are shown. C. IFNa production from the generated pDCs. The unit of measurement for IFNa production, pg/106 cells/day, was based on
the starting number of sorted cells when they were seeded. The difference in IFNa production was significant (n = 3, p,.05).
doi:10.1371/journal.pone.0047952.g001
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a relatively high level of PDCA-1 as one specific marker for pDCs
in the analysis and sorting of unstimulated cells because antibodies
against Siglec-H have been shown to inhibit IFNa production in
pDCs [24]. PDCs also react with antibodies that recognize Ly6C
but it is controversial whether Ly6Chi or Ly6Clow pDCs, or both,
are capable of producing IFNa [16,25–27]. We found that bone
marrow B220hiLy6C+/low cells (shown in red gate), but not
B220hiLy6C2 cells (shown in black gate) or B220low cells (gate not
shown), were positive for PDCA-1 (Fig. 3A). We also found that
although the numbers of pDCs were similar between Rag2+/+ and
Rag22/2 mice (Fig. S1), Rag22/2 pDCs expressed a higher level
of Ly6C than Rag2+/+ pDCs (Fig. 3A and 3B, comparing the red
gates), with the phenomenon especially evident in the spleen
(Fig. 3B), suggesting phenotypic variation of pDCs according to
Rag2 expression.
Because Ly6C is also expressed on CD11b+ monocytes/
macrophages [28], we excluded CD11b+ cells by gating on
CD11c+CD11b2 cells (Fig. 3C). These cells were expanded by
Flt3 ligand, a cytokine known to promote pDC development
and proliferation [29–31], regardless of Rag2 expression
(Fig. 3C). However, under both untreated and Flt3 ligand-
treated conditions, Ly6C expression was higher in
CD11c+CD11b2 cells lacking Rag2 than their wildtype or
Rag12/2 counterparts (Fig. 3C and Fig. S2). These results
suggest that Rag2 may be important for certain function(s) of
pDCs that are related to Ly6C expression, such as the
production of IFNa [16,26,27].
Figure 2. Preferential expression of Rag2 in pDCs. A. Rag1 and Rag2 expression in B cells, pDCs, and other cells in the mouse bone
marrow. Bone marrow (BM) cells were isolated from wildtype mice and sorted for B cell, pDCs, and other cells. Total RNA was isolated from
different subpopulations of cells and RT-qPCR was performed. Rag1 and Rag2 mRNA levels were normalized to L32 and the expression levels in
non-B/non-pDC cells were defined as 1. The difference in Rag2 expression between B cells and pDCs was significant (n = 3, p,.05). B.
Morphologic difference between bone marrow-derived Rag2+/+ and Rag22/2 pDCs. Bone marrow cells were isolated from Rag2+/+ and Rag22/2
mice and pDCs were sorted. Single cell suspensions were cytospinned onto slides, air-dried, stained, and examined on an Olympus BX-51
microscope (406 objective lens) and photographed using a Spot Digital Camera. Two representative images for each type of mice are shown.
Bar represents 5 mm.
doi:10.1371/journal.pone.0047952.g002
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Rag22/2 pDC Defective at IFNa Production upon TLR9
Stimulation
PDCs express and secrete IFNa in response to viral infection
[32,33] or TLR ligation [1,34]. To determine the effect of Rag2 on
this primary function of pDCs, we stimulated wildtype, Rag12/2, or
Rag22/2 bone marrow cells with CpG in vitro. Our result showed
that while wildtype (Rag2+/+) and Rag12/2 bone marrow cells
produced a large amount of IFNa in response to CpG, the induction
of IFNa was significantly lower in Rag22/2 bone marrow cells
(Fig. 4A, left panel, p,.05; and Fig. S3), suggesting that Rag2may be
required for TLR9-mediated production of IFNa in the bone
marrow.NeitherRag2+/+norRag22/2 cells derived from the spleen
produced a significant level of IFNa upon CpG stimulation (Fig. 4A,
right panel), consistent with previous reports [35,36]. Therefore, we
focused on bone marrow cells in the following experiments.
Different subpopulations of pDCs in the mouse bone marrow
have been found with differential IFNa-producing capacity
[16,25–27,36]. With regard to Ly6C expression, both Ly6Chi
pDCs [16,25] and Ly6Clow pDCs [26,27] have been shown to
produce IFNa. We found that isolated bone marrow cells that
expressed a high level of Ly6C, which might include both pDCs
and monocytes/macrophages, were poor producers of IFNa in
response to CpG stimulation (Fig. 4B, left panel). The Ly6C2/low
population of Rag2+/+ bone marrow cells, on the other hand,
Figure 3. Rag2+/+ and Rag22/2 pDCs different in Ly6C expression. A. Analysis of bone marrow cells isolated from Rag2+/+ and Rag22/2 mice.
B220hiLy6C2 cells were gated with a black gate and are shown as black lines in the CD11c and PDCA-1 histograms. B220hiLy6C+/low cells were gated
with a red gate and are shown as red lines in the CD11c and PDCA-1 histograms. Representative plots of 3 independent experiments are shown. B.
Analysis of splenocytes isolated from Rag2+/+ and Rag22/2 mice. B220+Ly6C2 and B220+Ly6C+/low cells were gated and analyzed as described in A.
Note that in both bone marrow and spleen, the expression level of Ly6C in the Rag22/2 red gate was higher than that in the Rag2+/+ red gate. C. Ly6C
expression during Flt3 ligand-mediated expansion of CD11b2CD11c+ cells. Total bone marrow cells were either untreated or treated with Flt3 ligand
for 5 days. CD11b2CD11c+ cells were gated and analyzed for Ly6C expression. Representative plots of 3 independent experiments are shown.
doi:10.1371/journal.pone.0047952.g003
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Figure 4. Rag22/2 pDCs defective at IFNa production upon CpG stimulation. A. CpG-induced IFNa production in bone marrow cells but not
in splenocytes. Bone marrow cells (left panel) and splenocytes (right panel) were isolated from Rag2+/+ and Rag22/2 mice. Cells were either not
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responded well to CpG and produced a large amount of IFNa
(Fig. 4B, right panel), suggesting that the production of IFNa may
correlate with a lower expression level of Ly6C. However, the
Ly6C2/low fraction of Rag22/2 bone marrow cells produced
a significant lower amount of IFNa than their Rag2+/+ counter-
parts in response to CpG stimulation (Fig. 4B, right panel; p,.05),
likely because there were fewer Ly6Clow pDCs in Rag22/2 bone
marrow cells (Fig. 3A and 3C). In addition, we found that isolated
PDCA-1+ Rag22/2 pDCs produced a significantly lower level of
IFNa than isolated PDCA-1+ Rag2+/+ pDCs upon CpG
stimulation (Fig. 4C; p,.05). These results suggest that Rag22/2
pDCs, expressing a high level of Ly6C, are defective at producing
IFNa upon TLR9 ligation in vitro. We also tested the effect of
TLR7/8 ligand Gardiquimod on bone marrow-derived pDCs and
did not find any difference in IFNa production with or without
Rag2 (data not shown), suggesting that the defect in Rag22/2
pDCs may be restricted to TLR9-mediated induction of IFNa.
We next examined the effect of Rag2 on IFNa production in
vivo. The basal concentrations of IFNa in the mouse plasma were
similar in Rag2+/+ and Rag22/2 mice (Fig. 4D). However, the
CpG-induced level of IFNa appeared to be different between the
two types of mice (Fig. 4E). To increase CpG uptake by pDCs in
vivo, we used a cationic lipid DOTAP that helps the localization of
negatively charged CpG oligonucleotide in the early endosomes
[37,38] and injected the CpG/DOTAP complex intravenously to
target pDCs in the peripheral blood and bone marrow. Our result
showed that IFNa was rapidly induced upon CpG stimulation in
Rag2+/+ mice (Fig. 4E). The IFNa-producing cells became
refractory to a secondary stimulation, consistent with the reported
kinetics of IFNa response in pDCs [39]. In contrast, Rag22/2
mice did not have any change in IFNa levels in response to either
primary or secondary CpG stimulation (Fig. 4E), suggesting that
Rag2 may be required for TLR9-mediated IFNa production in
vivo. Lastly, we confirmed that the defect of IFNa production in
Rag22/2 pDCs was not due to a decrease in TLR9 expression
(Fig. 4F).
Rag22/2 pDC Normal in other Functions
TLR ligation in pDCs not only triggers IFNa production but
also induces the expression of pDC functional markers, such as
CCR7, CD40, and CD86 [33]. CCR7 mediates the migration of
pDCs to lymph nodes [40,41]. CD40L can activate pDCs through
CD40 [42] and CD40L-activated pDCs can regulate adaptive
immunity by inducing T helper 1 polarization in T cells [43,44].
The co-stimulatory molecule CD86, on the other hand, has been
shown to be upregulated in pDCs upon TLR ligation [44]. We
found that all 3 functional markers were induced in bone marrow-
derived PDCA-1+ cells by CpG stimulation regardless of Rag2
expression (Fig. 5), indicating that Rag2 may not be required for
the induction of these markers.
PDCs link innate and adaptive immunity by producing type I
interferons and other cytokines [1]. One important function of
pDCs in the regulation of adaptive immunity is to promote plasma
cell formation and antibody class switching in B cells through
producing IFNa and IL-6 [45,46]. Because Rag22/2 pDC are
defective at producing IFNa (Fig. 4), we asked whether the lack of
Rag2 would block the function of pDCs in antibody class
switching and plasma cell formation. To examine this, CD11c-
depleted wildtype splenocytes were co-cultured, or cultured in
a transwell system, with bone marrow-derived Rag2+/+ or Rag22/
2 pDCs. As anticipated, Rag2+/+ pDCs significantly promoted
antibody class switching (Fig. 6A–B, from IgM to IgG) and plasma
cell formation (Fig. 6C) under the co-culture condition, suggesting
that close proximity between pDCs and B cells may be required.
Importantly, Rag22/2 pDCs were also able to promote antibody
class switching and plasma cell formation (Fig. 6A–C), suggesting
that the lack of Rag2 may not block the function of pDCs in
supporting B cells. We next asked whether IL-6 mediated the
effect of Rag22/2 pDCs on antibody class switching from IgM to
stimulated (NS) or stimulated with ODN1585 (CpG) in vitro for 5 days. Production of IFNa in the medium was measured by using ELISA. The asterisk
represents significant difference (n = 4, p,.05) between the CpG-induced IFNa levels in Rag2+/+ versus Rag22/2 bone marrow cells. B. CpG-induced
IFNa production in Ly6C2/low bone marrow cells. Bone marrow cells were isolated from Rag2+/+ and Rag22/2 mice and separated according to Ly6C
expression. The left panel shows the Ly6Chi population whereas the right panel shows the Ly6C2/low population. Cells were either not stimulated (NS)
or stimulated with ODN1585 (CpG) in vitro for 2 days. Production of IFNa in the medium was measured by using ELISA. The asterisk shows that,
within the Ly6C2/low population, there was significant difference (n = 4, p,.05) between the CpG-induced IFNa levels in Rag2+/+ versus Rag22/2 cells.
C. Rag22/2 PDCA-1+ pDCs defective at CpG-induced IFNa production. Bone marrow cells were isolated from Rag2+/+ and Rag22/2 mice and PDCA-1+
pDCs were sorted. Cells were either not stimulated (NS) or stimulated with ODN1585 (CpG) in vitro for 5 days. Production of IFNa in the medium was
measured and the asterisk represents significant difference (n = 3, p,.05) between the CpG-induced IFNa levels in Rag2+/+ versus Rag22/2 pDCs. D.
Plasma levels of IFNa in Rag2+/+ and Rag22/2 mice. The two groups are not significantly different (n = 8; p..05). E. In vivo response to CpG. Rag2+/+
and Rag22/2 mice (n = 3 per group) were treated with ODN1585/DOTAP complex (CpG) intravenously at 0 and 24 h. Mice were tail-bled every 2 h
for up to 8 h after each CpG injection. Plasma levels of IFNa were measured by using ELISA. The asterisks represent significant differences (p,.05)
between plasma IFNa levels in Rag2+/+ versus Rag22/2 mice at 6, 8, and 32 h. F. TLR9 expression. Bone marrow cells were isolated from Rag2+/+ and
Rag22/2 mice and stained for surface PDCA-1 and intracellular TLR9 expression. The histogram shown is a representation of 3 independent
experiments and has been pre-gated on PDCA-1+ cells. The shaded peak represents isotype control and the dashed and solid lines represent Rag2+/+
and Rag22/2 pDCs, respectively.
doi:10.1371/journal.pone.0047952.g004
Figure 5. CCR7, CD40 and CD86 induction with CpG in PDCA-1+
cells regardless of Rag2 expression. Bone marrow cells were
isolated from Rag2+/+ and Rag22/2 mice and stimulated with ODN1585
in vitro for 4 days. The expression levels of CCR7, CD40, and CD86 in
untreated (shaded peaks) and CpG-stimulated (solid lines) bone marrow
cells are shown. The histograms shown are a representation of 3
independent experiments and have been pre-gated on PDCA-1+ cells.
doi:10.1371/journal.pone.0047952.g005
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IgG. We found that both Rag2+/+ and Rag22/2 pDCs naturally
secreted IL-6 (Fig. 6D) and that a blocking antibody against IL-6
was able to abolish the effects of both types of pDCs on antibody
class switching (Fig. 6E–F), suggesting that although Rag22/2
pDCs are defective at producing IFNa, they are able to support
antibody class switching through producing IL-6.
Altogether, these results suggest that in pDCs, Rag2 specifically
regulates CpG-mediated induction of IFNa, whereas other
functions of pDCs may be intact in the absence of Rag2.
Dysregulation of IRF8 in Rag22/2 pDCs
To elucidate the mechanism by which Rag2 regulates CpG-
mediated induction of IFNa in pDCs, we examined the expression
level of IRF8, a transcription factor important for both pDC
development [47] and IFNa production [48]. We found that
during the expansion of pDCs by Flt3 ligand, IRF8 mRNA was
dramatically upregulated in bone marrow-derived wildtype and
Rag12/2 pDCs (Fig. 7A and Fig. S4). Rag22/2 pDCs, however,
expressed IRF8 at a significantly lower level upon the stimulation
(Fig. 7A, p,.05). This suggests that pDCs may be developmentally
impaired in the absence of Rag2. In addition, we examined the
change of IRF8 mRNA levels over time after CpG stimulation.
We found that IRF8 mRNA was slightly upregulated in Rag2+/+
but not Rag22/2 pDCs (Fig. 7B). The levels of IRF8 mRNA was
significantly lower in Rag22/2 pDCs at 3 h and 5 h after CpG
stimulation (Fig. 7B, p,.05), which might have led to a significant
difference in the magnitude of IFNa production observed between
Rag2+/+ and Rag22/2 pDCs (Fig. 7C, p,.05). These results
suggest that IRF8 expression is dysregulated in Rag22/2 pDCs,
which might be one reason why CpG-mediated IFNa production
is defective in pDCs lacking Rag2.
Discussion
Using Rag22/2 mice, we have found that pDCs as main
producers of IFNa require Rag2 for normal development. This is
a novel function for Rag2, whose classical role is to initiate B and
T cell development. Our results showed that, although the
Figure 6. PDCs capable of supporting antibody class switching and plasma cell formation regardless of Rag2 expression. A-C. CD11c-
depleted wildtype splenocytes (56105 cells per well) were either co-cultured, or culture in a transwell system, with medium (No pDC) or bone
marrow-derived, MACS-sorted Rag2+/+ or Rag22/2 pDCs (2.56105 sorted cells per well) for 5 days. IgM (A) and IgG (B) production was measured by
using ELISAs. The percentages of CD138+ plasma cells at the end of the cultures are shown in C. The asterisks show significant differences (n = 4,
p,.05) compared to the No pDC control under the co-culture condition. D. IL-6 production by Rag2+/+ and Rag22/2 pDCs. CD11c-depleted wildtype
splenocytes were either co-cultured, or culture in a transwell system, with medium (No pDC) or sorted Rag2+/+ or Rag22/2 pDCs for 5 days. IL-6
production was measured by using ELISA. The asterisks show significant differences (n = 3, p,.05) compared to the No pDC control under the co-
culture condition. E-F. Antibody class switching dependent on IL-6. CD11c-depleted wildtype splenocytes were co-cultured with medium (No pDC) or
sorted Rag2+/+ or Rag22/2 pDCs for 5 days in the presence of either isotype control or an anti-IL-6 blocking antibody. IgM (E) and IgG (F) production
was measured by using ELISAs.
doi:10.1371/journal.pone.0047952.g006
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numbers of pDCs were similar between Rag2+/+ and Rag22/2
mice, Rag22/2 pDCs produced a significantly lower level of IFNa
in vitro and in vivo in response to CpG, a ligand for TLR9. Flt3
ligand, a known stimulator of pDC proliferation, could expand
Rag22/2 pDCs in vitro; however, the expanded cells expressed
a high level of Ly6C. These Ly6Chi pDCs were defective at
producing IFNa in response to CpG. In contrast, Rag22/2 pDCs
retained the function to induce CCR7, CD40, and CD86 with
CpG. They were also able to promote antibody class switching
and plasma cell formation through producing IL-6. These results
suggest Rag2 as a novel regulator of IFNa production in pDCs.
During B and T cell development, Rag2 couples with Rag1 to
regulate V(D)J recombination. Although Rag2 is generally thought
to function by pairing with Rag1, recent evidence has shown that
only Rag2 is essential for maintaining genomic stability since
knockout of this protein, but not knockout of Rag1, on p532/2
background leads to rapid formation of thymic lymphomas [49].
This suggests that Rag2 may have unique functions that are not
shared by Rag1. We show here that Rag22/2 pDCs expressed
a high level of Ly6C but Rag12/2 pDCs expressed a similar
amount of Ly6C as wildtype pDCs (Fig. 3C and Fig. S2). In
addition, Rag22/2 bone marrow cells had a defect in CpG-
mediated IFNa induction but Rag12/2 bone marrow cells did not
(Fig. 4A, left panel and Fig. S3). Moreover, while IRF8 mRNA was
dramatically upregulated by Flt3 ligand in both wildtype and
Rag12/2 pDCs, the increase of IRF8 was much lower in pDCs
lacking Rag2 (Fig. 7A and Fig. S4). The lack of such defects in
Rag12/2 pDCs suggests that maturing pDCs may not need the
presence of lymphocytes to become fully competent. These
observations also suggest that Rag2 may be able to function
separately from Rag1.
PDCs as main producer of IFNa function as fine tuners of
immune responses. An inadequate amount of IFNa due to the lack
of functional pDCs can lead to uncontrolled viral infection and/or
cancer [1]. Too much of IFNa, on the other hand, can cause
autoimmune disorders [50]. Therefore, the function of pDCs to
produce IFNa must be tightly controlled. This function of pDCs
parallels the production of IFNa by conventional dendritic cells,
which is mediated by retinoic acid-inducible gene I (RIG-I)-
dependent signaling [51]. The production of IFNa by pDCs,
however, is triggered through TLR7 and TLR9 ligation [34]. The
TLR-mediated signaling cascade involves myeloid differentiation
primary response gene 88 (MyD88)/tumor necrosis factor re-
ceptor-associated factor 6 (TRAF6)/interleukin 1 receptor-associ-
ated kinase 1 (IRAK1) pathway and subsequent phosphorylation
of IRF7. It has also been shown that TLR-mediated induction of
IFNa in pDCs requires phosphatidylinositol-3-OH kinase (PI3K)/
Akt/mammalian target of rapamycin (mTOR) signaling pathway
[52] and nuclear factor-kB (NF-kB) and p38 mitogen-activated
protein kinase (MAPK) signaling pathways [53]. Recently, an
antiviral protein that is induced by interferon signaling has been
shown to promote TLR-mediated IFNa production in pDCs,
suggesting a positive feedback loop that controls the primary
function of pDCs to produce IFNa [54]. We show here that Rag2
also regulates IFNa production in pDCs. In addition, we have
found that Rag2 regulates IFNa production without affecting
other functions of pDCs–which include the expression of surface
functional markers and the support of antibody class switching–
suggesting that Rag2 may specifically regulate the signaling events
leading to IFNa induction.
We focused on IRF8 to elucidate the role of Rag2 in IFNa
induction because this transcription factor is involved in not only
IFNa induction, but also pDC development. IFNa is induced in
two phases upon viral infection [48]. The second amplifying
phase, which produces more IFNa than the first phase, requires
IRF8. IRF8 is also required for the pDC maturation [47], a process
that is facilitated by Flt3 ligand and inhibited by granulocyte
macrophage colony-stimulating factor (GM-CSF) [55]. In order
for GM-CSF to block pDC formation, it uses signal transducers
and activators of transcription-5 (STAT5) to directly suppress the
expression of IRF8 [56]. In this study, we determined IRF8
expression in Rag22/2 versus Rag2+/+ pDCs upon Flt3 ligand or
Figure 7. Dysregulation of IRF8 expression in Rag22/2 pDCs. A. Induction of IRF8 mRNA expression in pDCs with Flt3 ligand. PDCA-1+ pDCs
were sorted and either untreated (NS) or treated with Flt3 ligand (Flt3L) for 5 days. Total RNA was isolated and RT-qPCR was performed. IRF8 mRNA
levels were normalized to L32 and the expression level in Rag2+/+ pDC without stimulation was defined as 1. The difference in Flt3L-induced IRF8
expression between Rag2+/+ and Rag22/2 pDCs was significant (n = 3, p,.05). B. Time course of IRF8 mRNA expression in pDCs upon CpG
stimulation. Rag2+/+ and Rag22/2 PDCA-1+ pDCs were sorted and treated with ODN1585 (CpG) for 1, 3, 5, or 7 h. Total RNA was isolated and RT-qPCR
was performed. IRF8 mRNA levels were normalized to L32 and the expression level in Rag2+/+ pDC without stimulation was defined as 1. The asterisks
represent significant differences (n = 3, p,.05) between IRF8 levels in Rag2+/+ versus Rag22/2 pDCs at 3 and 5 h. C. Time course of IFNa production
in pDCs upon CpG stimulation. Rag2+/+ and Rag22/2 PDCA-1+ pDCs were sorted and treated with ODN1585 (CpG) for 1, 3, 5, or 7 h. IFNa production
were measured by using ELISA. The asterisks represent significant differences (n = 3, p,.05) between IFNa levels in Rag2+/+ versus Rag22/2 pDCs at 5
and 7 h.
doi:10.1371/journal.pone.0047952.g007
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CpG stimulation, and found that IRF8 mRNA was dysregulated
in pDCs lacking Rag2 (Fig. 7). How Rag2 is involved in the
dysregulation of IRF8 and whether additional pDC-specific
transcription factor such as E2-2 [57,58] are altered in Rag22/2
pDCs require further investigation. In addition, it has been
recently reported that CCR92MHC-IIlow pDCs produce more
IFNa than CCR9+MHC-II+ pDCs [22]. We did not observe any
difference in MHC-II expression between Rag2+/+ and Rag2/2
pDCs (data not shown), but we have not analyzed CCR9 and will
be interested in investigating whether Rag2 regulates CCR9
expression in future studies. We are also interested in knowing
whether pDCs isolated from Rag22/2 mice would differ in the
expression of Rag1 and other B-lineage associated genes.
Furthermore, we will try other TLR stimulations and compare
the response to those triggered by TLR9 ligands. TLR7/8 and
TLR9 ligands have been shown to trigger different inflammatory
responses [59] and it will be also interesting to find out why CpG-
mediated, but not TLR7/8 ligand-mediated production of IFNa,
is affected by Rag2 expression.
Overall, our results have shown that Rag2, an essential protein
for B and T cell development, may be also important for the
development of the primary function of pDCs as professional
interferon-producing cells. This suggests a common early de-
velopmental path for B/T cells and pDCs. This also suggests Rag2
as a novel therapeutic target for the treatment of excessive
interferons such as those in autoimmune disorders.
Supporting Information
Figure S1 Numbers of pDCs in the mouse bone
marrow. Bone marrow cells from wildtype (WT), Rag12/2,
and Rag22/2 mice (n = 4 in each group) were isolated, counted,
and analyzed by using flow cytometry. The percentages of PDCA-
1+ pDCs were determined and used to calculate the numbers of
pDCs.
(TIF)
Figure S2 Ly6C expression during Flt3 ligand-mediated
expansion of Rag12/2 CD11b2CD11c+ cells. Rag12/2
total bone marrow cells were either untreated or treated with Flt3
ligand for 5 days. CD11b2CD11c+ cells were gated and analyzed
for Ly6C expression. Representative plots of 3 independent
experiments are shown.
(TIF)
Figure S3 Rag12/2 pDCs normal at IFNa production
upon CpG stimuation. Bone marrow cells were isolated from
wildtype (WT) and Rag12/2 mice (n = 4 in each group). Cells
were either not stimulated (NS) or stimulated with ODN1585
(CpG) in vitro for 5 days. Production of IFNa in the medium was
measured by using ELISA.
(TIF)
Figure S4 IRF8 mRNA expression in pDCs upon Flt3
ligand stimulation. Wildtype (WT) or Rag12/2 PDCA-1+
pDCs (n = 3 in each group) were sorted and either untreated (NS)
or treated with Flt3 ligand (Flt3L) for 5 days. Total RNA was
isolated and RT-qPCR was performed. IRF8 mRNA levels were
normalized to L32 and the expression level in WT pDC without
stimulation was defined as 1.
(TIF)
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